Kenneth Allan Brasel

Title: The Innovations of Kenneth Allan Brasel

Introduction

Kenneth Allan Brasel is a notable inventor based in Seattle, Washington. He has made significant contributions to the field of biotechnology, particularly in the development of antigen binding proteins. With a total of seven patents to his name, Brasel's work has the potential to impact cancer treatment and immunology.

Latest Patents

Brasel's latest patents include innovative technologies related to human C-FMS antigen binding proteins. These proteins are designed to bind to the human c-fms protein, which plays a crucial role in monocyte migration and tumor-associated macrophage accumulation. His patents also encompass nucleic acids encoding these antigen binding proteins, as well as vectors and cells that facilitate their use. The implications of these inventions are significant, as they can inhibit the binding of c-fms to CSF-1, thereby reducing monocyte migration into tumors.

Career Highlights

Throughout his career, Kenneth Allan Brasel has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Amgen Inc. and Innunex Corporation. His experience in these organizations has contributed to his expertise and success as an inventor.

Collaborations

Brasel has collaborated with several professionals in his field, including James F. Smothers and Douglas Pat Cerretti. These collaborations have likely enriched his work and led to further advancements in his research.

Conclusion

Kenneth Allan Brasel is a distinguished inventor whose work in antigen binding proteins holds promise for advancements in cancer treatment. His contributions to biotechnology continue to influence the field and inspire future innovations.